Google Stitch introduces vibe designing to create app UI with AI using text or voice and preview interactive flows instantly.

The UEFA Champions League round-of-16 bracket was officially revealed, setting up a thrilling finish to the premier event. Round-of-16 matches begin on March 10, so there is still time to join UCL ...

Looking ahead: The first official visual upgrade in Minecraft's 16-year history was released last June for Bedrock Edition players. However, the original Java version has a long road ahead of it ...

Ready to play a game starring Stitch on Disney+? Or maybe create some kind of personalized, AI-animated version of the chaotic but oh-so-adorable alien from “Lilo & Stitch” you can share with your ...

Disney has been taking action to protect its intellectual property from the ravages of generative artificial intelligence—but it’s also taking steps to harness generative AI for its own benefit. In an ...

Disney CEO Bob Iger hinted at "productive conversations" with unnamed AI companies that would protect IP but add new features to the studio's flagship streaming service. By Tony Maglio Don’t want to ...

Disney+ subscribers could soon be getting “game-like features” in the not too distant future, and it has artificial intelligence (AI) to thank, according to Bob Iger. The media giant is also looking ...

As AI makes it easier to create bots that act ever more human-like, Elon Musk’s X is developing a new feature that would expose more information about the users behind an X profile in an effort to ...

We’ve placed hundreds of millions of teens in Teen Accounts across Instagram, Facebook, and Messenger, and now we’re expanding them to teens around the world on Facebook and Messenger. We’re launching ...

If you're in an interracial relationship, there can be additional concerns even with lots of love and care: cultural misunderstandings, family members who say hurtful things, disagreements over values ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.